Quantitative three-dimensional analysis and diffusion modeling of oligonucleotide concentrations after direct intraparenchymal brain infusion
暂无分享,去创建一个
John E. Stewart | William C. Broaddus | George T. Gillies | Peter J. Haar | Sujit S. Prabhu | G. Gillies | W. Broaddus | S. Prabhu | J. Stewart | P. J. Haar
[1] C. Patlak,et al. Intrathecal chemotherapy: brain tissue profiles after ventriculocisternal perfusion. , 1975, The Journal of pharmacology and experimental therapeutics.
[2] N. Tamaki,et al. Biomechanics of hydrocephalus: a new theoretical model. , 1987, Neurosurgery.
[3] R. Penn,et al. Direct delivery of medication into a brain tumor through multiple chronically implanted catheters. , 1987, Neurosurgery.
[4] C. Nicholson,et al. Long distance pathways of diffusion for dextran along fibre bundles in brain. Relevance for volume transmission , 1995, Neuroreport.
[5] Y. Nievergelt. Fitting density functions and diffusion tensors to three-dimensional drug transport within brain tissue. , 1990 .
[6] C. Nicholson,et al. Quantitative analysis of extracellular space using the method of TMA+ iontophoresis and the issue of TMA+ uptake. , 1992, Canadian journal of physiology and pharmacology.
[7] G. Aldis,et al. Flow-induced deformation from pressurized cavities in absorbing porous tissues. , 1992, Bulletin of mathematical biology.
[8] R. Diasio,et al. Pharmacokinetics and tissue distribution in rats of an oligodeoxynucleotide phosphorothioate (GEM 91) developed as a therapeutic agent for human immunodeficiency virus type-1. , 1995, Biochemical pharmacology.
[9] R K Jain,et al. Transport of molecules in the tumor interstitium: a review. , 1987, Cancer research.
[10] P F Morrison,et al. Convection-enhanced distribution of large molecules in gray matter during interstitial drug infusion. , 1995, Journal of neurosurgery.
[11] J Fenstermacher,et al. Drug “Diffusion” within the Brain a , 1988, Annals of the New York Academy of Sciences.
[12] W. Saltzman,et al. Millimeter-scale positioning of a nerve-growth-factor source and biological activity in the brain. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[13] W. Mark Saltzman,et al. Distribution of nerve growth factor following direct delivery to brain interstitium , 1995, Brain Research.
[14] V D Calhoun,et al. A finite element model for predicting the distribution of drugs delivered intracranially to the brain. , 1997, The American journal of physiology.
[15] G. Aldis,et al. Comparison of models for flow induced deformation of soft biological tissue. , 1990, Journal of biomechanics.
[16] W. Mark Saltzman,et al. Drugs released from polymers: diffusion and elimination in brain tissue , 1991 .
[17] H. Weiss,et al. Increased Blood–Brain Permeability with Hyperosmolar Mannitol Increases Cerebral O2 Consumption and O2 Supply/Consumption Heterogeneity , 1996, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[18] C. Nicholson,et al. Hindered diffusion of high molecular weight compounds in brain extracellular microenvironment measured with integrative optical imaging. , 1993, Biophysical journal.
[19] Charles Nicholson,et al. Ion-selective microelectrodes and diffusion measurements as tools to explore the brain cell microenvironment , 1993, Journal of Neuroscience Methods.
[20] G T Gillies,et al. Antiproliferative effect of c-myc antisense phosphorothioate oligodeoxynucleotides in malignant glioma cells. , 1997, Neurosurgery.
[21] E. Oldfield,et al. Efficacy of direct intratumoral therapy with targeted protein toxins for solid human gliomas in nude mice. , 1994, Journal of neurosurgery.
[22] B. Chiasson,et al. Infusion into the brain of an antisense oligonucleotide to the immediate-early gene c-fos suppresses production of Fos and produces a behavioral effect , 1994, Neuroscience.
[23] R. Diasio,et al. In vivo stability and disposition of a self-stabilized oligodeoxynucleotide phosphorothioate in rats. , 1995, Clinical chemistry.
[24] W. Saltzman,et al. Pharmacokinetics of interstitial delivery of carmustine, 4-hydroperoxycyclophosphamide, and paclitaxel from a biodegradable polymer implant in the monkey brain. , 1998, Cancer research.
[25] P. Basser. Interstitial pressure, volume, and flow during infusion into brain tissue. , 1992, Microvascular research.
[26] A. Krieg,et al. Problems in interpretation of data derived from in vitro and in vivo use of antisense oligodeoxynucleotides. , 1994, Antisense research and development.
[27] A. Friedman,et al. Interstitial chemotherapy with drug polymer implants for the treatment of recurrent gliomas. , 1991, Journal of neurosurgery.
[28] G. Gillies,et al. Distribution and stability of antisense phosphorothioate oligonucleotides in rodent brain following direct intraparenchymal controlled-rate infusion. , 1997, Journal of neurosurgery.
[29] E. Oldfield,et al. Tumor regression with regional distribution of the targeted toxin TF-CRM107 in patients with malignant brain tumors , 1997, Nature Medicine.
[30] D. Graves,et al. The biophysics of DNA hybridization with immobilized oligonucleotide probes. , 1995, Biophysical journal.
[31] S. Hakim,et al. Biomechanics of hydrocephalus. , 1971, Acta neurologica latinoamericana.
[32] R. Diasio,et al. Absorption, tissue distribution and in vivo stability in rats of a hybrid antisense oligonucleotide following oral administration. , 1995, Biochemical pharmacology.
[33] J. Chaires,et al. Insights from a new analytical electrophoresis apparatus. , 1996, Journal of pharmaceutical sciences.
[34] G T Gillies,et al. Distribution of macromolecular dyes in brain using positive pressure infusion: a model for direct controlled delivery of therapeutic agents. , 1998, Surgical neurology.
[35] Dillehay Le. Decreasing resistance during fast infusion of a subcutaneous tumor. , 1997 .
[36] R. Penn,et al. Stereotactic administration of intratumoral chronic chemotherapy of recurrent malignant gliomas. , 1987, Applied neurophysiology.
[37] P F Morrison,et al. High-flow microinfusion: tissue penetration and pharmacodynamics. , 1994, The American journal of physiology.
[38] P F Morrison,et al. Transport of cisplatin in rat brain following microinfusion: an analysis. , 1986, Journal of pharmaceutical sciences.
[39] E. Oldfield,et al. Chronic interstitial infusion of protein to primate brain: determination of drug distribution and clearance with single-photon emission computerized tomography imaging. , 1997, Journal of neurosurgery.
[40] J. Minna,et al. Osmotic blood-brain barrier modification: monoclonal antibody, albumin, and methotrexate delivery to cerebrospinal fluid and brain. , 1985, Neurosurgery.
[41] S. Agrawal,et al. Pharmacokinetics, biodistribution, and stability of oligodeoxynucleotide phosphorothioates in mice. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[42] Nicolas de Tribolet,et al. Outwitting the Blood-Brain Barrier for Therapeutic Purposes: Osmotic Opening and Other Means , 1998 .
[43] C. Nicholson,et al. Ion diffusion modified by tortuosity and volume fraction in the extracellular microenvironment of the rat cerebellum. , 1981, The Journal of physiology.
[44] G T Gillies,et al. Strategies for the design and delivery of antisense oligonucleotides in central nervous system. , 2000, Methods in enzymology.
[45] S. Agrawal,et al. Cellular uptake of oligodeoxynucleotide phosphorothioates and their analogs. , 1994, Antisense research and development.
[46] J. Kroin. Which Drugs, What Space? , 1988, Annals of the New York Academy of Sciences.
[47] R. Penn,et al. Intracerebral chemotherapy: chronic microinfusion of cisplatin. , 1982, Neurosurgery.
[48] P F Morrison,et al. Convection-enhanced delivery of macromolecules in the brain. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[49] Eva Syková,et al. The Extracellular Space in the CNS: Its Regulation, Volume and Geometry in Normal and Pathological Neuronal Function , 1997 .
[50] J. García de la Torre,et al. Hydrodynamic properties of a double-helical model for DNA. , 1994, Biophysical journal.
[51] C. Patlak,et al. The Movements of Water and Solutes in the Brains of Mammals , 1976 .
[52] R S Fisher,et al. Local Perfusion of Diazepam Attenuates Interictal and Ictal Events in the Bicuculline Model of Epilepsy in Rats , 1997, Epilepsia.
[53] R. Penn,et al. Intratumoral Chemotherapy with Multiple Sources , 1988, Annals of the New York Academy of Sciences.
[54] J. Tonkinson,et al. Phosphorothioate oligodeoxynucleotides--anti-sense inhibitors of gene expression? , 1991, Pharmacology & therapeutics.
[55] Charles Nicholson,et al. Diffusion from an injected volume of a substance in brain tissue with arbitrary volume fraction and tortuosity , 1985, Brain Research.
[56] H. Winn,et al. Intracerebral drug delivery in rats with lesion-induced memory deficits. , 1989, Journal of neurosurgery.
[57] V D Calhoun,et al. A finite element model for predicting the distribution of drugs delivered intracranially to the brain. , 1997, American journal of physiology. Regulatory, integrative and comparative physiology.
[58] L. Neckers,et al. Stability, clearance, and disposition of intraventricularly administered oligodeoxynucleotides: implications for therapeutic application within the central nervous system. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[59] R K Jain,et al. Transport of fluid and macromolecules in tumors. I. Role of interstitial pressure and convection. , 1989, Microvascular research.
[60] A. Marmarou,et al. Clearance of brain edema and macromolecules through the cortical extracellular space. , 1992, Journal of neurosurgery.
[61] Y. Cheng,et al. Antisense oligonucleotides as therapeutic agents--is the bullet really magical? , 1993, Science.
[62] J. Maizel,et al. Inhibition of human immunodeficiency virus in early infected and chronically infected cells by antisense oligodeoxynucleotides and their phosphorothioate analogues. , 1989, Proceedings of the National Academy of Sciences of the United States of America.